Islet cell transplantation for the treatment of type 1 diabetes
Record ID 32005000038
English
Authors' objectives:
Islet cell transplantation is performed in patients with type 1 (insulin-dependent) diabetes mellitus, with the goals of eliminating the need for exogenous insulin and improving glucose control, thereby preventing or reversing secondary diabetic complications, such as retinopathy, neuropathy, nephropathy, and vasculopathy.
Authors' methods:
Review
Details
Project Status:
Completed
Year Published:
2004
URL for published report:
http://www.hayesinc.com/hayes/crd/?crd=2178
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Diabetes Mellitus, Type 1
- Islets of Langerhans Transplantation
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
HAYES, Inc.
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.